Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome


Creative Commons License

MEYNIEL C., SPELMAN T., JOKUBAITIS V. G. , TROJANO M., IZQUIERDO G., GRAND'MAISON F., ...Daha Fazla

PLOS ONE, cilt.7, 2012 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Objectives: We conducted a prospective study, MSBASIS, to assess factors leading to first treatment discontinuation in patients with a clinically isolated syndrome (CIS) and early relapsing-remitting multiple sclerosis (RRMS).